Page last updated: 2024-10-28

hydralazine and Chemical and Drug Induced Liver Injury, Chronic

hydralazine has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 1 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Chemical and Drug Induced Liver Injury, Chronic: Liver disease lasting six months or more, caused by an adverse effect of a drug or chemical. The adverse effect may be caused by drugs, drug metabolites, chemicals from the environment, or an idiosyncratic response.

Research Excerpts

ExcerptRelevanceReference
"Hydralazine is a commonly prescribed antihypertensive agent."1.62Hydralazine-induced liver injury: a review and discussion. ( Bhardwaj, M; Bhardwaj, NJ; Cueto, K; Killeen, TC, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bhardwaj, M1
Bhardwaj, NJ1
Cueto, K1
Killeen, TC1

Other Studies

1 other study available for hydralazine and Chemical and Drug Induced Liver Injury, Chronic

ArticleYear
Hydralazine-induced liver injury: a review and discussion.
    BMJ case reports, 2021, Aug-17, Volume: 14, Issue:8

    Topics: Antihypertensive Agents; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Inj

2021